# Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction

> **NCT06383897** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 116 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HS-10398
- **DRUG:** HS-10398 Placebo

## Key facts

- **NCT ID:** NCT06383897
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-31
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06383897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06383897, "Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06383897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*